At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SEEQ™ Performance Study
In Brief
An observational study for Arrhythmia Type Unknown. Completed, enrolled 200 participants across 9 sites.
Detailed Summary
The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia Type Unknown
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJun 2015
Primary CompletionApr 2016
Study CompletionAug 2016
TodayJul 2026
First PostedJun 30, 2015
Enrollment StartJun 1, 2015
Primary CompletionApr 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.0 years ago